
Arena Pharmaceuticals ARNA
Geschäftsbericht 2021
hinzugefügt 16.12.2023
Arena Pharmaceuticals DIO 2011-2025 | ARNA
DIO Jährlich Arena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 160 | 263 | 510 | 754 | 602 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 754 | 160 | 458 |
DIO anderer Aktien in der Pharmaeinzelhändler
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
42.1 | $ 3.39 | 1.02 % | $ 262 M | ||
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 1.32 | -0.75 % | $ 7.2 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 89.7 | -0.64 % | $ 96.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
132 | $ 25.67 | -0.87 % | $ 1.24 B | ||
|
Anika Therapeutics
ANIK
|
247 | $ 9.55 | 0.63 % | $ 140 M | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.33 | 2.19 % | $ 14.6 M | ||
|
Baudax Bio
BXRX
|
596 | - | 0.59 % | $ 63 K | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
114 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
116 | $ 573.02 | -1.38 % | $ 43.4 B | ||
|
Caladrius Biosciences
CLBS
|
35.8 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
271 | - | -7.23 % | $ 13 M | ||
|
Biogen
BIIB
|
394 | $ 174.8 | 1.33 % | $ 25.5 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.04 K | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
239 | $ 11.54 | 0.87 % | $ 746 M | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 15.4 | 0.59 % | $ 1.01 B | ||
|
Epizyme
EPZM
|
754 | - | - | $ 249 M | ||
|
Cerus Corporation
CERS
|
213 | $ 2.22 | 3.02 % | $ 410 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K |